Exploring your options for Atypical Parkinsonism Management in India? Ginger Healthcare brings together a carefully chosen panel of reputed neurologists, practising at world-class hospitals accredited by JCI and NABH. Request a free opinion and a cost estimate from any doctor on the list, and our team will guide you through every step of your journey.
Here are the most reputed doctors in India for Atypical Parkinsonism Management. Each specialist is carefully vetted for their expertise, experience, and patient outcomes.
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Here are the most reputed hospitals in India for Atypical Parkinsonism Management. These hospitals are known for advanced infrastructure, international accreditations, and high success rates.
Atypical parkinsonism — also called Parkinson-plus syndromes — is an umbrella term for a group of progressive neurological conditions that share features with Parkinson's disease but involve broader brain damage, faster progression, and a poorer response to standard Parkinson's medications. The four main types are Multiple System Atrophy (MSA), Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD), and Dementia with Lewy Bodies (DLB), each with its own pattern of movement, autonomic, cognitive, and behavioural symptoms. There is currently no cure or disease-modifying treatment, so care focuses on relieving symptoms, preventing complications such as falls and aspiration, and maintaining quality of life for as long as possible. Management is inherently multidisciplinary, combining specialist neurology input, targeted medications for movement and non-motor symptoms, and intensive rehabilitation therapies covering physiotherapy, speech, and occupational therapy.
A comprehensive neurological assessment to confirm the type of atypical parkinsonism followed by personalised medication management for movement, autonomic, and non-motor symptoms — the foundation of all care pathways.
Estimated cost: ~$500 – $1,000
Typical tests: Brain MRI with dedicated brainstem and midbrain sequences, Lying and standing blood pressure (orthostatic assessment), Neuropsychological battery (cognition, attention, executive function), CBC, metabolic panel (blood sugar, kidney function, liver function), Thyroid function tests (to exclude treatable causes), ECG, Urinalysis and post-void residual bladder ultrasound (if bladder symptoms present), Sleep study (polysomnography) if REM sleep behaviour disorder or stridor suspected. Done in India before admission.
Estimated cost in India: $1,500 – $3,000
Treatment duration in India: ~2 weeks (~5 hospital visit days across the full span)
An intensive, structured inpatient or day-programme combining physiotherapy for balance and gait, speech and language therapy for voice and swallowing, and occupational therapy for daily living — the most effective intervention for maintaining function and safety.
Estimated cost: ~$500 – $1,000
Typical tests: Videofluoroscopic swallowing study (VFSS) or clinical swallowing assessment, Standardised gait and balance assessment (Berg Balance Scale, UPDRS-III), Neuropsychological screening for cognitive rehabilitation planning, CBC and metabolic panel (blood sugar, kidney and liver function), ECG, Lying and standing blood pressure, Chest X-ray (baseline aspiration risk assessment). Done in India before admission.
Estimated cost in India: $2,500 – $5,000
Treatment duration in India: ~3 weeks (~14 hospital visit days across the full span)
A combined inpatient programme integrating full neurological re-evaluation, medication optimisation, and intensive multidisciplinary rehabilitation in a single stay — ideal for international patients seeking maximum benefit from one visit to India.
Estimated cost: ~$1,000 – $1,500
Typical tests: Brain MRI with dedicated brainstem and midbrain sequences, DaT scan (if not done within 12 months), Videofluoroscopic swallowing study (VFSS), Autonomic function battery — lying/standing BP, heart rate variability, Neuropsychological battery, CBC, metabolic panel, thyroid function, ECG and chest X-ray, Urodynamic study (if significant bladder symptoms), Sleep study (polysomnography) if clinically indicated. Done in India before admission.
Estimated cost in India: $3,500 – $6,000
Treatment duration in India: ~4 weeks (~18 hospital visit days across the full span)
From your first enquiry to recovery back home — we manage every detail so you can focus on getting better.
Join 5,000+ patients from 40+ countries who chose world-class care at a fraction of the cost.
